Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis

Nature

Volumn 479, Issue 7371, 2011, Pages 122-126

  Takeda, Yukiji ^a,b   Costa, Sandra ^a,b,c   Delamarre, Estelle ^a,b   Roncal, Carmen ^a,b,d   Leite De Oliveira, Rodrigo ^a,b   Squadrito, Mario Leonardo ^e,f   Finisguerra, Veronica ^a,b   Deschoemaeker, Sofie ^a,b   Bruyère, Françoise ^a,b   Wenes, Mathias ^a,b   Hamm, Alexander ^a,b   Serneels, Jens ^a,b   Magat, Julie ^g   Bhattacharyya, Tapan ^h,l   Anisimov, Andrey ⁱ   Jordan, Benedicte F ^g   Alitalo, Kari ⁱ   Maxwell, Patrick ^h   Gallez, Bernard ^g   Zhuang, Zhen W ^j   Saito, Yoshihiko ^k   Simons, Michael ^j   De Palma, Michele ^e,m   Mazzone, Massimiliano ^a,b   more..

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF MINHO   (Portugal)

^d UNIVERSITY OF NAVARRA   (Spain)

^e SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^g UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NARA MEDICAL UNIVERSITY   (Japan)

^l LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^m EPFL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; PROTEIN PHD2; UNCLASSIFIED DRUG;

ABNORMALITY; BLOOD; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CYTOLOGY; DISEASE TREATMENT; GROWTH RATE; HOMEOSTASIS; MEDICINE; MUSCLE; OXYGEN; SENSOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; FEMALE; GENE DELETION; HAPLOINSUFFICIENCY; HEART INFARCTION; HOMEOSTASIS; ISCHEMIA; LIMB ISCHEMIA; LIMB PERFUSION; MACROPHAGE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TISSUE NECROSIS;

ALLELES; ANIMALS; ARTERIES; DISEASE MODELS, ANIMAL; EXTREMITIES; FEMALE; HETEROZYGOTE; HOMEOSTASIS; ISCHEMIA; MACROPHAGES; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED BALB C; MYOCYTES, SMOOTH MUSCLE; NECROSIS; NF-KAPPA B; PHENOTYPE; PROCOLLAGEN-PROLINE DIOXYGENASE;

MUS;

EID: 80455122752     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10507     Document Type: Article

References (34)

1. Mazzone, M. et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136, 839-851 (2009).
2. Milkiewicz, M., Pugh, C. W. & Egginton, S. Inhibition of endogenous HIF inactivation induces angiogenesisinischaemicskeletal musclesofmice.J. Physiol. (Lond.) 560, 21-26 (2004). (Pubitemid 39406013)
3. Nangaku, M. et al. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia. Arterioscler. Thromb. Vasc. Biol. 27, 2548-2554 (2007). (Pubitemid 350158904)
4. Huang, M. et al. Short hairpin RNA interference therapy for ischemic heart disease. Circulation 118, S226-S233 (2008).
5. Loinard, C. et al. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization. Circulation 120, 50-59 (2009).
6. Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. Nature Med. 6, 389-395 (2000). (Pubitemid 30208155)
7. Simons, M. & Ware, J. A. Therapeutic angiogenesis in cardiovascular disease. Nature Rev. Drug Discov. 2, 863-872 (2003).
8. Schaper, W. Collateral circulation: past and present. Basic Res. Cardiol. 104, 5-21 (2009).
9. Mantovani, A. & Sica, A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22, 231-237 (2010).
10. Nucera, S., Biziato, D. & De Palma, M. The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. Int. J. Dev. Biol. 55, 495-503 (2011).
11. Aragonés, J. et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nature Genet. 40, 170-180 (2008). (Pubitemid 351171394)
12. Helisch, A. et al. Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler. Thromb. Vasc. Biol. 26, 520-526 (2006).
13. Squadrito, M. L. & De Palma, M. Macrophage regulation of tumor angiogenesis: Implications for cancer therapy. Mol. Aspects Med. 32, 123-145 (2011).
14. Kumar,M.S.&Owens,G.K.Combinatorialcontrolofsmooth muscle-specificgene expression. Arterioscler. Thromb. Vasc. Biol. 23, 737-747 (2003).
15. Wolf, C. et al. Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J. Mol. Cell. Cardiol. 30, 2291-2305 (1998). (Pubitemid 28549981)
16. Karshovska, E., Zagorac, D., Zernecke, A., Weber, C. & Schober, A. A small molecule CXCR4 antagonist inhibits neointima formation and smooth muscle progenitor cell mobilization after arterial injury. J. Thromb. Haemost. 6, 1812-1815 (2008).
17. Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A. & Betsholtz, C. Role of PDGF-B andPDGFR-binrecruitmentofvascularsmooth musclecells andpericytes during embryonic blood vessel formation in the mouse. Development 126, 3047-3055 (1999). (Pubitemid 29378170)
18. 2-regulated prolyl hydroxylation. Science 292, 468-472 (2001). (Pubitemid 32335942)
19. Chan,D. A. etal. Tumor vasculature is regulated byPHD2-mediated angiogenesis and bone marrow-derived cell recruitment. Cancer Cell 15, 527-538 (2009).
20. Xue, J. et al. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKb independent of hydroxylase activity. Gastroenterology 138, 606-615 (2010).
21. Cummins, E. P. et al. Prolyl hydroxylase-1 negatively regulates IkB kinase-b, giving insight into hypoxia-induced NFkB activity. Proc. Natl Acad. Sci. USA 103, 18154-18159 (2006). (Pubitemid 44871628)
22. Fu, J. & Taubman, M. B. Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kB-dependent pathway. J. Biol. Chem. 285, 8927-8935 (2010).
23. Mantovani, A., Garlanda, C. & Locati, M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler. Thromb. Vasc. Biol. 29, 1419-1423 (2009).
24. Fong, C. H. et al. An antiinflammatory role for IKKb through the inhibition of "classical" macrophage activation. J. Exp. Med. 205, 1269-1276 (2008). (Pubitemid 351831484)
25. Hagemann, T. et al. "Re-educating" tumor-associated macrophages by targeting NF-kB. J. Exp. Med. 205, 1261-1268 (2008). (Pubitemid 351831483)
26. Greten, F. R. et al. NF-kB is a negative regulator of IL-1b secretion as revealed by genetic and pharmacological inhibition of IKKb. Cell 130, 918-931 (2007). (Pubitemid 47332565)
27. Luttun, A. et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nature Med. 8, 831-840 (2002).
28. Meerpohl, H. G., Lohmann-Matthes, M. L.& Fischer, H.Studies on the activation of mouse bonemarrow-derived macrophagesbythe macrophage cytotoxicityfactor (MCF). Eur. J. Immunol. 6, 213-217 (1976).
29. Foo, S. S. et al. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124, 161-173 (2006). (Pubitemid 43069317)
30. Benedito, R. et al. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137, 1124-1135 (2009).
31. Chen, L. W. et al. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nature Med. 9, 575-581 (2003).
32. Lutgens, E. et al. Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovasc. Res. 41, 586-593 (1999). (Pubitemid 29130622)
33. Jordan, B. F., Cron, G. O. & Gallez, B. Rapid monitoring of oxygenation by 19F magnetic resonance imaging: Simultaneous comparison with fluorescence quenching. Magn. Reson. Med. 61, 634-638 (2009).
34. Pfeffer, M. A. et al. Myocardial infarct size and ventricular function in rats. Circ. Res. 44, 503-512 (1979). (Pubitemid 9170880)